Acumen Pharmaceuticals Inc (ABOS)

$2.57 -0.02 (-0.77%)
Market Cap 157.49M
Revenue (ttm) 0.00
Net Income (ttm) -102.33M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.33
Volume 549,400
Avg Vol 627,402
Day's Range N/A - N/A
Shares Out 60.57M
Stochastic %K 61%
Beta 0.23
Analysts Strong Sell
Price Target $7.25

Company Profile

Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops targeted therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate Sabirnetug (ACU193), a recombinant humanized immunoglobulin gamma 2, which has completed the INTERCEPT-AD phase 1 clinical trial and in ALTITUDE-AD phase 2 clinical trial to target soluble amyloid-beta oligomers. It has a collaboration and license agreement with Halozyme, Inc. for t...

Industry: Biotechnology
Sector: Healthcare
Phone: 617 344 4190
Address:
1210-1220 Washington St., Suite 210, Newton, United States
jacksparo
jacksparo Feb. 2 at 9:39 PM
$SLS $ALT $IBRX $OCGN $ABOS Market closed . Time to review today volume and other related info 📈✅📈!
1 · Reply
Stockley_Bulbousberries
Stockley_Bulbousberries Feb. 2 at 8:01 PM
$ABOS lovely
0 · Reply
h714
h714 Feb. 2 at 7:02 PM
$ABOS have a small position
0 · Reply
Johndoe456
Johndoe456 Jan. 30 at 8:12 PM
$ABOS
0 · Reply
B00merang
B00merang Jan. 29 at 4:17 PM
$ABOS start your engines.
0 · Reply
sssssssssssssAhmed
sssssssssssssAhmed Jan. 29 at 2:26 PM
$ABOS Today will be our day
2 · Reply
StockScanners
StockScanners Jan. 29 at 4:33 AM
$ABOS reached 2.90
0 · Reply
Stock_Catcher
Stock_Catcher Jan. 29 at 2:25 AM
New Video out on the Bullish Analysis on $ARBB $BNAI $BGL $ABOS $SEGG and more stocks that can Rip ! https://www.youtube.com/watch?v=nCOm_uEyME4
0 · Reply
toxicdogie
toxicdogie Jan. 28 at 8:21 PM
$ABOS Adddd more!!! So undervalued thus bio
0 · Reply
kevben
kevben Jan. 28 at 8:05 PM
$ABOS biotech small-cap, quiet coil with catalyst-dr
0 · Reply
Latest News on ABOS
Acumen Pharmaceuticals, Inc. (ABOS) Q3 2025 Earnings Call Transcript

Nov 12, 2025, 3:01 PM EST - 2 months ago

Acumen Pharmaceuticals, Inc. (ABOS) Q3 2025 Earnings Call Transcript

Acumen Pharmaceuticals, Inc. (ABOS) Presents At Citi's Biopharma Back To School Conference Transcript

Sep 2, 2025, 9:28 PM EDT - 5 months ago

Acumen Pharmaceuticals, Inc. (ABOS) Presents At Citi's Biopharma Back To School Conference Transcript

Acumen Pharmaceuticals to Participate in Upcoming Investor Conferences

Aug 26, 2025, 4:00 PM EDT - 5 months ago

Acumen Pharmaceuticals to Participate in Upcoming Investor Conferences

Acumen Pharmaceuticals, Inc. (ABOS) Q2 2025 Earnings Call Transcript

Aug 12, 2025, 2:46 PM EDT - 6 months ago

Acumen Pharmaceuticals, Inc. (ABOS) Q2 2025 Earnings Call Transcript

Acumen Pharmaceuticals Reports Second Quarter 2025 Financial Results and Business Highlights

Aug 12, 2025, 7:00 AM EDT - 6 months ago

Acumen Pharmaceuticals Reports Second Quarter 2025 Financial Results and Business Highlights

Acumen Pharmaceuticals to Report Second Quarter 2025 Financial Results on August 12, 2025

Aug 5, 2025, 4:00 PM EDT - 6 months ago

Acumen Pharmaceuticals to Report Second Quarter 2025 Financial Results on August 12, 2025

JCR Pharmaceuticals and Acumen Pharmaceuticals Announce Collaboration to Develop Therapy for Alzheimer's Disease, Enabled by J-Brain Cargo® Technology Platform

Jul 15, 2025, 7:00 AM EDT - 7 months ago

JCR Pharmaceuticals and Acumen Pharmaceuticals Announce Collaboration to Develop Therapy for Alzheimer's Disease, Enabled by J-Brain Cargo® Technology Platform

Acumen Pharmaceuticals to Present Studies on Cost Savings Associated with Use of pTau217 Screening Assay in Phase 2 ALTITUDE-AD Study and Sabirnetug Oligomer-Selectivity at the Alzheimer's Association International Conference (AAIC®) 2025

Jul 10, 2025, 8:00 AM EDT - 7 months ago

Acumen Pharmaceuticals to Present Studies on Cost Savings Associated with Use of pTau217 Screening Assay in Phase 2 ALTITUDE-AD Study and Sabirnetug Oligomer-Selectivity at the Alzheimer's Association International Conference (AAIC®) 2025

Acumen Pharmaceuticals, Inc. (ABOS) Q1 2025 Earnings Call Transcript

May 13, 2025, 10:11 AM EDT - 9 months ago

Acumen Pharmaceuticals, Inc. (ABOS) Q1 2025 Earnings Call Transcript

Acumen Pharmaceuticals to Participate in the Bank of America Healthcare Conference

May 7, 2025, 4:00 PM EDT - 9 months ago

Acumen Pharmaceuticals to Participate in the Bank of America Healthcare Conference

Acumen Pharmaceuticals to Report First Quarter 2025 Financial Results on May 13, 2025

May 6, 2025, 4:00 PM EDT - 9 months ago

Acumen Pharmaceuticals to Report First Quarter 2025 Financial Results on May 13, 2025

Acumen Pharmaceuticals Showcases pTau217 Trial Screening Progress in Phase 2 ALTITUDE-AD Trial and Preclinical Research Methods at AD/PD 2025 and AAN Annual Meeting

Apr 2, 2025, 7:00 AM EDT - 10 months ago

Acumen Pharmaceuticals Showcases pTau217 Trial Screening Progress in Phase 2 ALTITUDE-AD Trial and Preclinical Research Methods at AD/PD 2025 and AAN Annual Meeting

Acumen Pharmaceuticals, Inc. (ABOS) Q4 2024 Earnings Call Transcript

Mar 27, 2025, 10:05 AM EDT - 11 months ago

Acumen Pharmaceuticals, Inc. (ABOS) Q4 2024 Earnings Call Transcript

Acumen Pharmaceuticals to Report Fourth Quarter and Year-End 2024 Financial Results on March 27, 2025

Mar 20, 2025, 4:00 PM EDT - 11 months ago

Acumen Pharmaceuticals to Report Fourth Quarter and Year-End 2024 Financial Results on March 27, 2025

Acumen Pharmaceuticals CEO Discusses Novel Targeted Therapies for Alzheimer's

Mar 18, 2025, 8:48 AM EDT - 11 months ago

Acumen Pharmaceuticals CEO Discusses Novel Targeted Therapies for Alzheimer's

Acumen Pharmaceuticals to Present During International Conference on Alzheimer's and Parkinson's Diseases 2025 and American Academy of Neurology Annual Meeting

Mar 12, 2025, 8:00 AM EDT - 11 months ago

Acumen Pharmaceuticals to Present During International Conference on Alzheimer's and Parkinson's Diseases 2025 and American Academy of Neurology Annual Meeting

Acumen Pharmaceuticals to Participate in the 7th Annual Evercore ISI HealthCONx Conference

Nov 26, 2024, 4:00 PM EST - 1 year ago

Acumen Pharmaceuticals to Participate in the 7th Annual Evercore ISI HealthCONx Conference

Acumen Pharmaceuticals, Inc. (ABOS) Q3 2024 Earnings Call Transcript

Nov 12, 2024, 1:17 PM EST - 1 year ago

Acumen Pharmaceuticals, Inc. (ABOS) Q3 2024 Earnings Call Transcript

Acumen Pharmaceuticals to Participate in the Stifel Healthcare Conference

Nov 11, 2024, 4:00 PM EST - 1 year ago

Acumen Pharmaceuticals to Participate in the Stifel Healthcare Conference

Acumen Pharmaceuticals to Participate in the UBS Global Healthcare Conference

Nov 6, 2024, 4:00 PM EST - 1 year ago

Acumen Pharmaceuticals to Participate in the UBS Global Healthcare Conference

Acumen Pharmaceuticals Presents Innovative Trial Screening Advancements Utilizing pTau217 Assay in Phase 2 Study of Sabirnetug for Early Alzheimer's Disease at the 17th Annual Clinical Trials on Alzheimer's Disease Conference

Oct 31, 2024, 8:05 AM EDT - 1 year ago

Acumen Pharmaceuticals Presents Innovative Trial Screening Advancements Utilizing pTau217 Assay in Phase 2 Study of Sabirnetug for Early Alzheimer's Disease at the 17th Annual Clinical Trials on Alzheimer's Disease Conference

Acumen Pharmaceuticals to Deliver Late-Breaking Presentation at 17th Annual Clinical Trials on Alzheimer's Disease (CTAD) Conference

Oct 23, 2024, 8:00 AM EDT - 1 year ago

Acumen Pharmaceuticals to Deliver Late-Breaking Presentation at 17th Annual Clinical Trials on Alzheimer's Disease (CTAD) Conference

Lucy Therapeutics Appoints Kim Drapkin as Board Chair

Oct 15, 2024, 8:00 AM EDT - 1 year ago

Lucy Therapeutics Appoints Kim Drapkin as Board Chair

LENZ

Acumen Pharmaceuticals to Participate in the Bank of America CNS Therapeutics Virtual Conference

Sep 30, 2024, 4:00 PM EDT - 1 year ago

Acumen Pharmaceuticals to Participate in the Bank of America CNS Therapeutics Virtual Conference

Acumen Pharmaceuticals to Host Virtual R&D Day on Oct. 2, 2024

Sep 25, 2024, 4:00 PM EDT - 1 year ago

Acumen Pharmaceuticals to Host Virtual R&D Day on Oct. 2, 2024

Acumen Pharmaceuticals to Participate in the H.C. Wainwright 26th Annual Global Investor Conference

Sep 3, 2024, 4:00 PM EDT - 1 year ago

Acumen Pharmaceuticals to Participate in the H.C. Wainwright 26th Annual Global Investor Conference

Acumen Pharmaceuticals, Inc. (ABOS) Q2 2024 Earnings Call Transcript

Aug 13, 2024, 11:17 AM EDT - 1 year ago

Acumen Pharmaceuticals, Inc. (ABOS) Q2 2024 Earnings Call Transcript

Acumen Pharmaceuticals to Report Second Quarter Results on August 13, 2024

Aug 6, 2024, 4:00 PM EDT - 1 year ago

Acumen Pharmaceuticals to Report Second Quarter Results on August 13, 2024

Acumen Pharmaceuticals: Healthy Cash Runway And Market Potential In Alzheimer's

Jul 29, 2024, 8:38 PM EDT - 1 year ago

Acumen Pharmaceuticals: Healthy Cash Runway And Market Potential In Alzheimer's

Acumen Pharmaceuticals Announces First Subject Dosed in Phase 1 Study of Subcutaneous Sabirnetug (ACU193) for Early Alzheimer's Disease

Jul 29, 2024, 7:00 AM EDT - 1 year ago

Acumen Pharmaceuticals Announces First Subject Dosed in Phase 1 Study of Subcutaneous Sabirnetug (ACU193) for Early Alzheimer's Disease

Acumen Pharmaceuticals Presents Patient Experience and Biomarker Data from Phase 1 INTERCEPT-AD Study at the Alzheimer's Association International Conference (AAIC®) 2024

Jul 28, 2024, 7:30 AM EDT - 1 year ago

Acumen Pharmaceuticals Presents Patient Experience and Biomarker Data from Phase 1 INTERCEPT-AD Study at the Alzheimer's Association International Conference (AAIC®) 2024

Acumen Pharmaceuticals, Inc. (ABOS) Q1 2024 Earnings Call Transcript

May 14, 2024, 12:46 PM EDT - 1 year ago

Acumen Pharmaceuticals, Inc. (ABOS) Q1 2024 Earnings Call Transcript

Acumen Pharmaceuticals Reports First Quarter 2024 Financial Results and Business Highlights

May 14, 2024, 7:00 AM EDT - 1 year ago

Acumen Pharmaceuticals Reports First Quarter 2024 Financial Results and Business Highlights

Acumen Pharmaceuticals to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference

May 13, 2024, 4:00 PM EDT - 1 year ago

Acumen Pharmaceuticals to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference

Acumen Pharmaceuticals to Participate in the 2024 Bank of America Healthcare Conference

May 8, 2024, 5:47 PM EDT - 1 year ago

Acumen Pharmaceuticals to Participate in the 2024 Bank of America Healthcare Conference

Acumen Pharmaceuticals Announces First Patient Dosed in ALTITUDE-AD, a Phase 2 Clinical Trial of Sabirnetug (ACU193) in Early Alzheimer's Disease

May 8, 2024, 8:00 AM EDT - 1 year ago

Acumen Pharmaceuticals Announces First Patient Dosed in ALTITUDE-AD, a Phase 2 Clinical Trial of Sabirnetug (ACU193) in Early Alzheimer's Disease

Acumen Pharmaceuticals to Report First Quarter Results on May 14, 2024

May 7, 2024, 4:00 PM EDT - 1 year ago

Acumen Pharmaceuticals to Report First Quarter Results on May 14, 2024

Acumen Pharmaceuticals Presents First Comprehensive Clinical and Biomarker Data for Sabirnetug (ACU193) at American Academy of Neurology 2024 Annual Meeting

Apr 16, 2024, 8:00 AM EDT - 1 year ago

Acumen Pharmaceuticals Presents First Comprehensive Clinical and Biomarker Data for Sabirnetug (ACU193) at American Academy of Neurology 2024 Annual Meeting

Acumen Pharmaceuticals Collaborates with Lonza to Advance Sabirnetug for the Treatment of Alzheimer's Disease

Apr 4, 2024, 8:00 AM EDT - 1 year ago

Acumen Pharmaceuticals Collaborates with Lonza to Advance Sabirnetug for the Treatment of Alzheimer's Disease

Acumen Pharmaceuticals, Inc. (ABOS) Q4 2023 Earnings Call Transcript

Mar 26, 2024, 10:45 AM EDT - 2 years ago

Acumen Pharmaceuticals, Inc. (ABOS) Q4 2023 Earnings Call Transcript

Acumen Pharmaceuticals Reports Financial Results for the Year Ended December 31, 2023 and Business Highlights

Mar 26, 2024, 7:00 AM EDT - 2 years ago

Acumen Pharmaceuticals Reports Financial Results for the Year Ended December 31, 2023 and Business Highlights

Acumen Pharmaceuticals to Report Fourth Quarter and Year-End 2023 Financial Results on March 26, 2024

Mar 19, 2024, 4:00 PM EDT - 2 years ago

Acumen Pharmaceuticals to Report Fourth Quarter and Year-End 2023 Financial Results on March 26, 2024

Acumen Pharmaceuticals to Participate in the Stifel 2024 CNS Days

Mar 12, 2024, 4:00 PM EDT - 2 years ago

Acumen Pharmaceuticals to Participate in the Stifel 2024 CNS Days

Acumen Pharmaceuticals Presents Sabirnetug (ACU193) Fluid Biomarker and Target Engagement Analyses from Phase 1 INTERCEPT-AD Study in Early Alzheimer's at the AD/PD™ 2024 Annual Meeting

Mar 8, 2024, 8:50 AM EST - 2 years ago

Acumen Pharmaceuticals Presents Sabirnetug (ACU193) Fluid Biomarker and Target Engagement Analyses from Phase 1 INTERCEPT-AD Study in Early Alzheimer's at the AD/PD™ 2024 Annual Meeting

Acumen Pharmaceuticals to Present Sabirnetug (ACU193) Fluid Biomarker and Target Engagement Analyses from Phase 1 INTERCEPT-AD Study in Early Alzheimer's at the AD/PD™ 2024 Annual Meeting

Feb 21, 2024, 8:00 AM EST - 2 years ago

Acumen Pharmaceuticals to Present Sabirnetug (ACU193) Fluid Biomarker and Target Engagement Analyses from Phase 1 INTERCEPT-AD Study in Early Alzheimer's at the AD/PD™ 2024 Annual Meeting

Acumen Pharmaceuticals Appoints Dr. James Doherty as President and Chief Development Officer

Feb 1, 2024, 7:00 AM EST - 2 years ago

Acumen Pharmaceuticals Appoints Dr. James Doherty as President and Chief Development Officer

Acumen Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Jan 4, 2024, 4:15 PM EST - 2 years ago

Acumen Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Acumen Pharmaceuticals, Inc. (ABOS) Q3 2023 Earnings Call Transcript

Nov 13, 2023, 4:29 PM EST - 2 years ago

Acumen Pharmaceuticals, Inc. (ABOS) Q3 2023 Earnings Call Transcript

Acumen Pharmaceuticals Secures $50.0 Million Credit Facility with K2 HealthVentures

Nov 13, 2023, 7:00 AM EST - 2 years ago

Acumen Pharmaceuticals Secures $50.0 Million Credit Facility with K2 HealthVentures

Acumen Pharmaceuticals Reports Third Quarter 2023 Financial Results and Business Highlights

Nov 13, 2023, 7:00 AM EST - 2 years ago

Acumen Pharmaceuticals Reports Third Quarter 2023 Financial Results and Business Highlights

jacksparo
jacksparo Feb. 2 at 9:39 PM
$SLS $ALT $IBRX $OCGN $ABOS Market closed . Time to review today volume and other related info 📈✅📈!
1 · Reply
Stockley_Bulbousberries
Stockley_Bulbousberries Feb. 2 at 8:01 PM
$ABOS lovely
0 · Reply
h714
h714 Feb. 2 at 7:02 PM
$ABOS have a small position
0 · Reply
Johndoe456
Johndoe456 Jan. 30 at 8:12 PM
$ABOS
0 · Reply
B00merang
B00merang Jan. 29 at 4:17 PM
$ABOS start your engines.
0 · Reply
sssssssssssssAhmed
sssssssssssssAhmed Jan. 29 at 2:26 PM
$ABOS Today will be our day
2 · Reply
StockScanners
StockScanners Jan. 29 at 4:33 AM
$ABOS reached 2.90
0 · Reply
Stock_Catcher
Stock_Catcher Jan. 29 at 2:25 AM
New Video out on the Bullish Analysis on $ARBB $BNAI $BGL $ABOS $SEGG and more stocks that can Rip ! https://www.youtube.com/watch?v=nCOm_uEyME4
0 · Reply
toxicdogie
toxicdogie Jan. 28 at 8:21 PM
$ABOS Adddd more!!! So undervalued thus bio
0 · Reply
kevben
kevben Jan. 28 at 8:05 PM
$ABOS biotech small-cap, quiet coil with catalyst-dr
0 · Reply
Asher32420
Asher32420 Jan. 28 at 2:07 PM
$ABOS volume
0 · Reply
toxicdogie
toxicdogie Jan. 28 at 9:58 AM
$ABOS $MRNO $AIMD $EHGO LFG!!
0 · Reply
StockScanners
StockScanners Jan. 28 at 5:45 AM
$ABOS keep watch if this holds above 2.70
0 · Reply
SadyK189
SadyK189 Jan. 28 at 4:45 AM
$ABOS Good close of daily candle. Key support at 2.1 - 2.3. Next key level to test is 3.6 - 3.85. Currently at 2.97
0 · Reply
Stock_Catcher
Stock_Catcher Jan. 28 at 3:02 AM
Wealthy Wednesday Watchlist Pt. 1 $RR $WBUY $ABOS $KUST $IVF Let's Find a Big Winner Tomorrow
4 · Reply
StockJelli
StockJelli Jan. 28 at 3:00 AM
Ok so from our momentum screener when this was posted $RR was 18% and ended at 44%. $ABOS 16% ➡️ 30%. $HYUA ended at the same. $NET went down to 8% so it ended positive, but cooled down. Will see what tomorrow brings.
0 · Reply
Johndoe456
Johndoe456 Jan. 28 at 1:50 AM
$ABOS
0 · Reply
TravisBking87
TravisBking87 Jan. 28 at 12:50 AM
$ABOS Worth every penny to join your group @jacksparo!
2 · Reply
Whiskey1679
Whiskey1679 Jan. 28 at 12:19 AM
Whiskey's Penny Picks out tomorrow! I'll have 1-2 picks. See my Pinned Time Stamped Post for this mornings winner. AH Gainers: $FFIV $NXT $TXN $ABOS $MCHP
0 · Reply
StockJelli
StockJelli Jan. 27 at 11:27 PM
$ABOS finished 4th in our momentum scanner today! 30%❗️
0 · Reply
zoneclassman1
zoneclassman1 Jan. 27 at 11:17 PM
$ABOS I made good money here thank you Jack!
0 · Reply
smarty2021
smarty2021 Jan. 27 at 11:02 PM
$ABOS Shorts are trapped on this stock. huge short squeeze coming today which will fly this stock up huge.this is best price to buy lots of shares now. Just added more and Holding huge size of shares! Patience is very important. This company got best news and tremendous potential for growth to move stock price at much higher levels. It will be flying up big today! Good luck all!
0 · Reply